DOES ANXIETY HAVE AN EFFECT ON WALKING DISTANCE IN INDIVIDUALS WITH COPD?

Year 2025, Volume: 8 Issue: 1, 71 - 79, 30.05.2025

Özlem Çınar Özdemir , Kübra Özonay

https://doi.org/10.52538/iduhes.1606586

Abstract

There are a limited number of studies in literature examining the relationship between anxiety and functional capacity in Chronic Obstructive Pulmonary Disease (COPD). The present study was planned to investigate whether anxiety has an effect on walking distance in individuals with COPD. 125 individuals who were diagnosed with COPD according to Global Initiative for Obstructive Lung Disease (GOLD) criteria were included in the current study. Sociodemographic data of the individuals were recorded. The walking distance was evaluated using the 6-Minute Walking Test. Anxiety level was assessed using the Anxiety Inventory Respiratory (AIR) Scale. The mean age of COPD patients included in this study was 66.1±9.011 years. The negative effect of the patient’s anxiety level on the walking distance was found statistically significant (Regression coefficient (B) (Standard error (SE)) = -5.618 (1.454), p<0.001). In addition, as the patient’s age increases, the walking distance shortens (B (SE) = -9.924 (0.985), p<0.001). In conclusion, anxiety level has a negative effect on walking distance in COPD patients in the stable period. Furthermore, as the patient's age increases, the walking distance decreases.

Keywords

Lung Diseses, COPD, Anxiety, Walking

Ethical Statement

Abant Izzet Baysal University Non-Interventional Clinical Research and Ethics Committee (2017/05).

KOAH’lı Bireylerde Anksiyetenin Yürüme Mesafesine Etkisi Var mıdır?

Abstract

Literatürde Kronik Obstrüktif Akciğer Hastalığı’nda (KOAH) anksiyete ve fonksiyonel kapasite arasındaki ilişkiyi inceleyen sınırlı sayıda çalışma bulunmaktadır. Bu çalışma, KOAH’lı bireylerde anksiyetenin yürüme mesafesi üzerine etkisi olup olmadığını araştırmak için planlandı. Çalışmaya Global Initiative for Obstructive Lung Disease (GOLD) kriterlerine göre KOAH tanısı konulan 125 birey dahil edildi. Bireylerin sosyodemografik verileri kaydedildi. Yürüme mesafesi 6 dakika yürüme testi ile değerlendirildi. Anksiyete düzeyi Anxiety Inventory Respiratory (AIR) Ölçeği ile değerlendirildi. Bu çalışmaya dahil edilen KOAH'lı hastaların yaş ortalaması 66,1±9,011 yıldı. Hastanın anksiyete düzeyinin yürüme mesafesi üzerine negatif etkisi istatistiksel olarak anlamlı bulundu (Regresyon katsayısı (B) (Standart hata (SE)) = -5,618 (1,454), p<0,001). Ek olarak, hastanın yaşı arttıkça yürüme mesafesi kısalmaktadır (B (SE) = -9.924 (0.985), p<0.001). Sonuç olarak, stabil dönemde KOAH hastalarında anksiyete düzeyinin yürüme mesafesi üzerinde negatif etkisi vardır. Ayrıca hastanın yaşı arttıkça yürüme mesafesi azalmaktadır.

Keywords

Akciğer Hastalıkları, KOAH, Anksiyete, Yürüme

References

• Adeloye, D., Chua, S., Lee, C., Basquill, C., Papana, A., Theodoratou, E., Nair, H., Gasevic, D., Sridhar, D., Campbell, H., Chan, K. Y., Sheikh, A., Rudan, I., & Global Health Epidemiology Reference Group (GHERG). (2015). Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. Journal of Global Health, 5(2), 020415.
• Altenburg, W. A., Bossenbroek, L., de Greef, M. H., Kerstjens, H. A., ten Hacken, N. H., & Wempe, J. B. (2013). Functional and psychological variables both affect daily physical activity in COPD: A structural equations model. Respiratory Medicine, 107(11), 1740-1747.
• Altindag, O., Uyar, M., Akaltun, M. S., Gürsoy, S., & Gür, A. (2021). Impact of pulmonary rehabilitation program with cycle ergometry in chronic obstructive pulmonary disease. Annals of Medical Research, 28(1), 172-177.
• American Thoracic Society (2002). Committee on proficiency standards for clinical pulmonary function laboratories. ATS statement: Guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine, 166(1), 111-117.
• Borak, J., Chodosowska, E., Matuszewski, A., & Zielinski, J. (1998). Emotional status does not alter exercise tolerance in patients with chronic obstructive pulmonary disease. European Respiratory Journal, 12(2), 370-373.
• COPD. https://www.nhlbi.nih.gov/health-topics/copd
• Doyle, T., Palmer, S., Johnson, J., Babyak, M. A., Smith, P., Mabe, S., Welty-Wolf, K., Martinu, T., & Blumenthal, J. A. (2013). Association of anxiety and depression with pulmonary-specific symptoms in chronic obstructive pulmonary disease. International Journal of Psychiatry in Medicine, 45(2), 189-202.
• Eisner, M. D., Blanc, P. D., Yelin, E. H., Katz, P. P., Sanchez, G., Iribarren, C., & Omachi, T. A. (2010). Influence of anxiety on health outcomes in COPD. Thorax, 65(3), 229-234.
• Garcia-Aymerich, J., Farrero, E., Felez, M. A., Izquierdo, J., Marrades, R. M., & Anto, J. M. (2003). Risk factors of readmission to hospital for a COPD exacerbation: A prospective study. Thorax, 58(2), 100-105.
• Global Initiative for Chronic Obstructive Lung Disease. Global Strategy 4ort the diagnosis and management of chronic obstructive pulmonary disease (GOLD), updated 2013.
• Giardino, N. D., Curtis, J. L., Andrei, A. C., Fan, V. S., Benditt, J. O., Lyubkin, M., Naunheim, K., Criner, G., Make, B., Wise, R. A., Murray, S. K., Fishman, A. P., Sciurba, F. C., Liberzon, I., Martinez, F. J., & the NETT Research Group. (2010). Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: A cross-sectional study. Respiratory Research, 11, 1-11.
• Hill, K., Geist, R., Goldstein, R. S., & Lacasse, Y. (2008). Anxiety and depression in end-stage COPD. European Respiratory Journal, 31(3), 667-677.
• Hynninen, K. M. J., Breitve, M. H., Wiborg, A. B., Pallesen, S., & Nordhus, I. H. (2005). Psychological characteristics of patients with chronic obstructive pulmonary disease: A review. Journal of Psychosomatic Research, 59(6), 429-443.
• Mazmanoğlu A. (2026). Herkes İçin Temel İstatistik Yöntemleri ve Uygulamaları. Nobel Akademik Yayıncılık, 550-638.
• Lin, F. L., Yeh, M. L., Lai, Y. H., Lin, K. C., Yu, C. J., & Chang, J. S. (2019). Two‐month breathing‐based walking improves anxiety, depression, dyspnoea, and quality of life in chronic obstructive pulmonary disease: A randomised controlled study. Journal of Clinical Nursing, 28(19-20), 3632-3640.
• Penña, V. S., Miravitlles, M., Gabriel, R., Jimenez-Ruiz, C. A., Villasante, C., Masa, J. F., Viejo, J. L., & Fernandez-Fau, L. (2000). Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest, 118(4), 981-989.
• Pommer, A. M., Pouwer, F., Denollet, J., & Pop, V. J. M. (2012). Managing co-morbid depression and anxiety in primary care patients with asthma and/or chronic obstructive pulmonary disease: study protocol for a randomized controlled trial. Trials, 13, 6-13.
• Seemungal, T. A., Donaldson, G. C., Paul, E. A., Bestall, J. C., Jeffries, D. J., & Wedzicha, J. A. (1998). Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 157(5), 1418-1422.
• Van Ede, L., Yzermans, C. J., & Brouwer, H. J. (1999). Prevalence of depression in patients with chronic obstructive pulmonary disease: A systematic review. Thorax, 54(8), 688-692.
• Weaver, T. E., Richmond, T. S., & Narsavage, G. L. (1997). An explanatory model of functional status in chronic obstructive pulmonary disease. Nursing Research, 46(1), 26-31.
• Willgoss, T. G., Goldbart, J., Fatoye, F., & Yohannes, A. M. (2013). The development and validation of the anxiety inventory for respiratory disease. Chest, 144(5), 1587-1596.
• Yohannes, A. M., & Willgoss, T. G. (2015). The accuracy of the anxiety inventory for respiratory disease scale for patients with COPD. International Journal of Geriatric Psychiatry, 30(1), 106-108.